Business Insider21h
Alkermes price target raised to $31 from $28 at BofA
BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer comps for the increased ...
Alkermes price target raised to $40 from $35 at Mizuho
Mizuho raised the firm’s price target on Alkermes (ALKS) to $40 from $35 and keeps an Outperform rating on the shares. The firm assessed ...
Opioid Withdrawal Treatment Market Size Expansion To USD 3.26 Billion By 2034, Driven By 10.1% CAGR - Report By VMR
Opioid Withdrawal Treatment market Rising Trends, Demand and Future Scope 2025 to 2034 ...
The New York Times15h
New York Times - Top Stories
At Mar-a-Lago, ‘Uncle’ Elon Musk Puts His Imprint on the Trump Transition He’s on the patio. He’s on the golf course. Everywhere President-elect Trump looks, there is the world’s richest ...